Clinical Trial Update: Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating sildenafil for COPD-associated pulmonary hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Aarhus | Conditions: COPD, Pulmonary Hypertension | Phase 4 | Status: WITHDRAWN